- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Daily Derm Times: April 1, 2025
Author(s):
Key Takeaways
- Dermatological meetings in April 2025 offer opportunities for professional development and networking.
- Vitiligo treatment requires patient education and realistic expectations due to the slow repigmentation process.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Dermatology Conferences and Meetings Calendar: April 2025
Dermatology Times has compiled a list of dermatological meetings taking place during the month of April.
Optimizing Vitiligo Care: Key Expert Takeaways
The significance of patient education and setting realistic expectations for the often-slow process of repigmentation in vitiligo treatment was a key focus of the discussion.
High-Intensity Ultrasound Device Is Suitable for Facial Acne Scars in Asian Patients
Nearly all patients saw improvements in small, medium, and large depressions on the cheeks and temples with just a singular treatment session.
Challenges and Future Directions in Microbiome Engineering
Microbiome engineering offers strategies to modulate the skin microbiome, including non-targeted approaches like probiotics and targeted approaches like phage therapy.
Salix purpurea Shampoo Supports Scalp Health in Patients with Dandruff and Erythema
2% and 4% formulations of the product were effective and tolerable for patients with varying scalp conditions.
Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum Confidence
Gooderham continues a discussion on new data reinforcing the safety of topical delgocitinib, with minimal systemic absorption even under maximal use conditions.
